Leon Cooperman's KZIA Position Overview
Leon Cooperman (via Cooperman Leon G) currently holds 50,000 shares of Kazia Therapeutics Limited (KZIA) worth $704,000, representing 0.02% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Leon Cooperman has initiated a new position in KZIA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Leon Cooperman's Kazia Therapeutics Limited (KZIA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kazia Therapeutics Limited (KZIA) Trades by Leon Cooperman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +50,000 | New Buy | 50,000 | $14.08 |
Leon Cooperman's Kazia Therapeutics Limited Investment FAQs
Leon Cooperman first purchased Kazia Therapeutics Limited (KZIA) in Q2 2026, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman has held Kazia Therapeutics Limited (KZIA) for 1 quarters since Q2 2026.
Leon Cooperman's largest addition to Kazia Therapeutics Limited (KZIA) was in Q2 2026, adding 50,000 shares worth $704,000.
According to the latest 13F filing for Q2 2026, Leon Cooperman's firm, Cooperman Leon G, owns 50,000 shares of Kazia Therapeutics Limited (KZIA), valued at approximately $704,000.
As of the Q2 2026 filing, Kazia Therapeutics Limited (KZIA) represents approximately 0.02% of Leon Cooperman's publicly disclosed stock portfolio, making it one of their key holdings.
Leon Cooperman's peak holding in Kazia Therapeutics Limited (KZIA) was 50,000 shares, as reported at the end of Q2 2026.